Monsenso A/S

MONSO

DK0061277977

IT Services & Consulting

Market Closed - Nasdaq Copenhagen Other stock markets 05:57:10 2024-04-26 am EDT			5-day change	1st Jan Change
0.448 ^DKK	+1.82%		+8.74%	+55.02%

Mar. 06	Monsenso A/S Reports Earnings Results for the Full Year Ended December 31, 2023	CI
Feb. 27	Monsenso A/S Provides Earnings Guidance for the Year 2023	CI

Monsenso A/S Revises Financial Guidance for the Year 2021

August 26, 2021 at 02:29 am EDT

Monsenso A/S revised financial guidance for the year 2021. Revenue guidance for 2021 is now DKK 9 million to DKK 10 million from previously announced DKK 9 million to DKK 12 million.

Latest news about Monsenso A/S

Monsenso A/S Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 06	CI
Monsenso A/S Provides Earnings Guidance for the Year 2023	Feb. 27	CI
Monsenso A/S Provides Earnings Guidance for the Year 2024	Feb. 27	CI
Monsenso to Deploy Patient Data Collection Platform to Unnamed Pharma Group	Nov. 01	MT
Monsenso A/S Signs New Agreement with Pharmaceutical for Real-World Data Project in Denmark	Nov. 01	CI
Monsenso A/S Reports Earnings Results for the Half Year Ended June 30, 2023	23-09-06	CI
Monsenso A/S Signs Major New Agreement with A European Capital	23-07-19	CI
Monsenso A/S Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-08	CI
Monsenso A/S Provides Earnings Guidance for the Full Year 2023	23-03-08	CI
European Community-Based Intervention Project Will Use Monsenso's Platform to Prevent Mental Illness	22-12-15	CI
Monsenso A/S Participates in New, Large Innovation Project	22-09-27	CI
Monsenso A/S Provides Revenue Guidance for the Full Year of 2022	22-08-31	CI
Monsenso A/S Reports Earnings Results for the Half Year Ended June 30, 2022	22-07-29	CI
Monsenso A/S Announces Board Changes	22-04-06	CI
Monsenso A/S Provides Earnings Guidance for the Year 2022	22-03-09	CI
Monsenso A/S Reports Earnings Results for the Full Year Ended December 31, 2021	22-03-09	CI
Monsenso Signs an Agreement with Awakn Life Sciences	21-11-09	CI
Monsenso Moves into a New Disorder Area with a New Project Covering Multiple Sclerosis	21-10-06	CI
Monsenso A/S Revises Financial Guidance for the Year 2021	21-08-26	CI
Monsenso A/S Reports Earnings Results for the First Half of 2021	21-08-26	CI
10,223,984 Shares of Monsenso A/S are subject to a Lock-Up Agreement Ending on 3-JUN-2021.	21-06-02	CI
Monsenso A/S Announces Board Changes	21-04-14	CI
Monsenso Expands in the Middle East with New Million-Kroner Agreement with Global Pharmaceutical Company	20-12-22	CI
Monsenso Signs New Agreement to Support Global Pharmaceutical Across Nine European Countries	20-08-21	CI
Monsenso Partners with A Pan-European Consortium in the Go Green Routes Research Project	20-08-07	CI

MONSENSO A/S is a Denmark-based medical software developer. The Companyâs provides SaaS, cloud-based solution that connects people with mental disorders and their relatives or caregivers with their clinician (therapist or physician) for the purpose of increased data collection, collaboration and communication. MONSENSO A/S develops possibilities for health prevention, early intervention, and psychological disorders treatments.

Sector

IT Services & Consulting

More about the company

Income Statement Evolution

More financial data

Annual profits - Rate of surprise

Company calendar

Sector Other IT Services & Consulting

	1st Jan change	Capi.
MONSENSO A/S	+55.02%	4.27M
ACCENTURE PLC	-12.23%	194B
TATA CONSULTANCY SERVICES LTD.	+0.74%	166B
IBM	+2.19%	153B
AUTOMATIC DATA PROCESSING, INC.	+4.34%	99.85B
RELX PLC	+7.04%	77.56B
CROWDSTRIKE HOLDINGS, INC.	+19.09%	73.55B
INFOSYS LIMITED	-7.30%	71B
SNOWFLAKE INC.	-20.54%	52.81B
HCL TECHNOLOGIES LIMITED	+0.53%	47.86B

Other IT Services & Consulting

Monsenso A/S

Equities

MONSO

DK0061277977

IT Services & Consulting

Monsenso A/S Revises Financial Guidance for the Year 2021

Latest news about Monsenso A/S

Chart Monsenso A/S

Company Profile

Income Statement Evolution

Annual profits - Rate of surprise

Sector Other IT Services & Consulting